目的对中药治疗特发性肺纤维化系统评价/Meta分析进行再评价研究,以期为临床医师及研究者提供更科学的决策支持。方法检索中药治疗特发性肺纤维化系统评价/Meta分析的文献,筛选文献后提取资料,采用AMSTAR2(A Measurement Tool To Assess...目的对中药治疗特发性肺纤维化系统评价/Meta分析进行再评价研究,以期为临床医师及研究者提供更科学的决策支持。方法检索中药治疗特发性肺纤维化系统评价/Meta分析的文献,筛选文献后提取资料,采用AMSTAR2(A Measurement Tool To Assess Systematic Reviews 2)量表和GRADE(Grade of Recommendation,Assessment,Development,and Evaluation)系统工具进行评估。结果共纳入14篇文献,106次结局指标;AMSTAR2量表结果示3篇属于低质量,11篇属于极低质量;GRADE分级显示,10次结局指标证据质量等级中等,83次等级低,13次等级极低。结论中药治疗特发性肺纤维化系统评价/Meta分析的方法学质量为低、极低,结局指标的证据质量等级多为低,高质量、证据强度高级别的系统评价亟需开展,从而作为高级别证据来指导临床。展开更多
Objective:In this study,we evaluated the methodological quality of systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions,aiming to provide evidence-based supp...Objective:In this study,we evaluated the methodological quality of systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions,aiming to provide evidence-based support and establish levels of evidence for clinical application.Method:A comprehensive search was conducted to identify systematic reviews on acupuncture and mox-ibustion for the prevention and management of cancer-related conditions,covering databases including PubMed,Embase,Cochrane Library,Web of Science,China National Knowledge Infrastructure,Chinese Biomedical Databases,China Science and Technology Journal Database,and Wanfang Data,from their in-ception to August 1,2024.The methodological quality of the included systematic reviews was assessed by using AMSTAR 2,and bubble plots were employed to visualize the evidence.Results:Overall,137 systematic reviews were included,with China being the most prolific country,with 117 reviews.These reviews addressed 21 cancer-related conditions,with the three most frequently stud-ied being cancer-related fatigue(25 reviews),nausea and vomiting(20 reviews),and cancer pain(19 re-views).The three most commonly used acupuncture modalities were manual acupuncture(81 reviews),electroacupuncture(55 reviews),and moxibustion(39 reviews).Quality assessment revealed that one systematic review was rated as“high quality,”eight as“low quality,”and 128 as“critically low quality,”primarily due to the absence of protocol registration and lists of excluded studies.Conclusion:Acupuncture and moxibustion have shown potential efficacy in alleviating cancer-related con-ditions and treatment-related adverse effects,and their clinical use has been widely reported.However,the overall methodological quality of the included systematic reviews was low,limiting the reliability and the strength of the evidence.Future high-quality studies are needed to improve the quality of evidence and support the standardized application and broader promotion of acupuncture and moxibustion clinical practice.展开更多
通过对中医药干预糖尿病视网膜病变的系统评价/Meta分析相关文献的证据进行分析,探索并呈现中医药干预糖尿病视网膜病变的证据质量。通过检索中国知网(CNKI)、万方(Wanfang)、维普(VIP)、中国生物医学文献服务系统(SinoMed)、PubMed、We...通过对中医药干预糖尿病视网膜病变的系统评价/Meta分析相关文献的证据进行分析,探索并呈现中医药干预糖尿病视网膜病变的证据质量。通过检索中国知网(CNKI)、万方(Wanfang)、维普(VIP)、中国生物医学文献服务系统(SinoMed)、PubMed、Web of Science、EMbase、Cochrane Library数据库,从建库至2023年11月发表的中医药干预糖尿病视网膜病变的系统评价/Meta分析。采用AMSTAR2量表对纳入文献进行方法学质量评价,并采用证据图谱综合呈现干预措施、系统评价/Meta分析纳入文献量、研究结论及方法学质量评价结果等信息。最终纳入51篇文献,干预措施中中药治疗占比较大,其次为中成药;治疗方法集中在补益法、活血法及化瘀法等。根据AMSTAR2量表评价结果显示,纳入文献基金资助信息、排除文献清单及前期研究方案等条目的阐述较差。证据图谱显示,中医药干预糖尿病视网膜病变有一定疗效,纳入文献中48篇结论为有益,2篇结论为可能有益,1篇为不清楚。总之,中医药干预糖尿病视网膜病变的相关研究证据质量整体为中等偏低,建议今后开展更高质量的相关研究以提供循证参考依据。展开更多
基金Supported by WFAS 2023 International Standard Project of Acupuncture-Moxibustion:WFASRP2023-SC05Tianjin Nankai District Pilot Demonstration Project for Integrated Inheritance and Innovation of Traditional Chinese Medicine:20250102001Beijing Natural Science:7252224。
文摘Objective:In this study,we evaluated the methodological quality of systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions,aiming to provide evidence-based support and establish levels of evidence for clinical application.Method:A comprehensive search was conducted to identify systematic reviews on acupuncture and mox-ibustion for the prevention and management of cancer-related conditions,covering databases including PubMed,Embase,Cochrane Library,Web of Science,China National Knowledge Infrastructure,Chinese Biomedical Databases,China Science and Technology Journal Database,and Wanfang Data,from their in-ception to August 1,2024.The methodological quality of the included systematic reviews was assessed by using AMSTAR 2,and bubble plots were employed to visualize the evidence.Results:Overall,137 systematic reviews were included,with China being the most prolific country,with 117 reviews.These reviews addressed 21 cancer-related conditions,with the three most frequently stud-ied being cancer-related fatigue(25 reviews),nausea and vomiting(20 reviews),and cancer pain(19 re-views).The three most commonly used acupuncture modalities were manual acupuncture(81 reviews),electroacupuncture(55 reviews),and moxibustion(39 reviews).Quality assessment revealed that one systematic review was rated as“high quality,”eight as“low quality,”and 128 as“critically low quality,”primarily due to the absence of protocol registration and lists of excluded studies.Conclusion:Acupuncture and moxibustion have shown potential efficacy in alleviating cancer-related con-ditions and treatment-related adverse effects,and their clinical use has been widely reported.However,the overall methodological quality of the included systematic reviews was low,limiting the reliability and the strength of the evidence.Future high-quality studies are needed to improve the quality of evidence and support the standardized application and broader promotion of acupuncture and moxibustion clinical practice.
文摘通过对中医药干预糖尿病视网膜病变的系统评价/Meta分析相关文献的证据进行分析,探索并呈现中医药干预糖尿病视网膜病变的证据质量。通过检索中国知网(CNKI)、万方(Wanfang)、维普(VIP)、中国生物医学文献服务系统(SinoMed)、PubMed、Web of Science、EMbase、Cochrane Library数据库,从建库至2023年11月发表的中医药干预糖尿病视网膜病变的系统评价/Meta分析。采用AMSTAR2量表对纳入文献进行方法学质量评价,并采用证据图谱综合呈现干预措施、系统评价/Meta分析纳入文献量、研究结论及方法学质量评价结果等信息。最终纳入51篇文献,干预措施中中药治疗占比较大,其次为中成药;治疗方法集中在补益法、活血法及化瘀法等。根据AMSTAR2量表评价结果显示,纳入文献基金资助信息、排除文献清单及前期研究方案等条目的阐述较差。证据图谱显示,中医药干预糖尿病视网膜病变有一定疗效,纳入文献中48篇结论为有益,2篇结论为可能有益,1篇为不清楚。总之,中医药干预糖尿病视网膜病变的相关研究证据质量整体为中等偏低,建议今后开展更高质量的相关研究以提供循证参考依据。
